Base Molecular Resonance™ Technologies Names Bryan Adams as Chief Marketing Officer

Executive Strategist to Lead Global Brand, Market Growth, and Cross-Vertical Commercialization for Quantum Detection Pioneer

STUART, Fla., Aug. 14, 2025 /PRNewswire/ -- Base Molecular Resonance™ Technologies (BMRT), the company behind a globally validated breakthrough in subatomic detection, today announced the appointment of Bryan Adams as Chief Marketing Officer. Adams joins the executive team as BMRT scales its multi-patented Base Molecular Resonance™ (BMR™) technology across high-value verticals including security, medical, defense, and beyond.

Base Molecular Resonance™ Technologies is not just a breakthrough in quantum physics, it's a technology with the power to reshape how we detect, diagnose, and defend," said Bryan Adams, Chief Marketing Officer of BMRT. "I'm deeply grateful to be working alongside such a talented team on something this meaningful. Few opportunities in life offer the chance to help save countless lives, and I'm honored to play a part in bringing this technology to the world."

With more than 20 years of experience at the intersection of marketing, data, and technology, Adams is a rare hybrid executive known for leading transformative growth across early-stage and enterprise environments. His leadership spans brand strategy, global commercialization, product innovation, and digital transformation, with a reputation for aligning marketing, product, and revenue teams to unlock market momentum.

"Bryan is not only an exceptional marketing mind, but also someone who understands how to position world-changing technology for commercial impact," said Robert "Bo" Short, Co-Founder and CEO of BMRT. "Having worked with him before, I've seen firsthand the clarity and velocity he brings to organizations. We are proud to welcome him to BMRT's executive team."

In his role as CMO, Adams will lead global marketing strategy, brand architecture, earned media, and digital experience. He will oversee strategic positioning, partnerships, and market growth across dozens of business verticals, including security, military and medical.

"Bryan's appointment adds tremendous horsepower to our leadership team," added Lee Duke, Co-Founder and President of BMRT. "He brings a systems-level approach to growth, integrating narrative, data, and execution. He has the rare ability to move between strategy and delivery, which is essential as we introduce this technology to a rapidly evolving global market."

BMRT's patented Base Molecular Resonance™ (BMR™) technology has been independently validated by the Centre for Applied Innovation at York St. John University in England, demonstrating 100% accuracy in blind and double-blind tests with no false-positives or negatives, both up close and at great distances. The technology enables non-invasive, real-time detection of every element on the periodic table, over 200 cancers and other diseases, and high-threat substances including weapons, explosives, and narcotics.

BMRT currently holds 20 patent assets and has received an independent $60.3 billion intellectual property valuation across 56 global use cases.

For more information, visit www.BMRT.io

Investment Inquiries
Robert "Bo "Short
Co-Founder & CEO
[email protected]

Media Contact
Bryan Adams
Chief Marketing Officer
[email protected]

About Base Molecular Resonance™ Technologies (BMRT)
BMRT has discovered a new area of quantum physics that utilizes resonant frequencies to detect particle interactions at subatomic levels. This technology, called Base Molecular Resonance™ (BMR™), can detect any compound or biological substance, including every element on the periodic table, and up to 200 cancers and other diseases. With over 20 years of prototyping and testing proving its unmatched detection capabilities, BMR™ has the potential to save millions of lives by pinpointing weapons, explosives, and other physical threats both up close and at great distances, and detecting cancers and other diseases long before they present clinical symptoms. The non-invasive, harmless, and instant scan has broad implications in Cancer Diagnostics, Public Safety, Law Enforcement, National Security, and Military Services.

Watch: How the Technology Works & Expert Reactions
This video explains the science behind BMRT's quantum physics-based technology and features insights from experts and leaders who have witnessed its capabilities firsthand.
https://vimeo.com/1105931418/8d56a0f610?share=copy

SOURCE Base Molecular Resonance Technologies, LLC